4th Quarter - Report

NOVAVAX, INC for NOVAVAX, INC

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to COVID-19 vaccines Reauthorization of Pandemic and All-Hazards Preparedness Act General discussions related to vaccine injury compensation programs and vaccine strain selection timelines. H.R.9027/S.4690 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act

LobbyistCovered position, as disclosed
JAMES CAMPOLONGO New —
KELLY CAPPIO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 9027 (118th), S. 4690 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.